© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#CROI 2016
Click Here for More Conferences
Click Here for CROI Online
An Introduction to Hepatitis

Can You Get Away With an Even Shorter Hepatitis C Treatment?

Research suggests that some people are taking hep C therapy for longer periods than they actually need.

Gilead’s Upcoming Hep C Treatment, Sovaldi/Velpatasvir, Is Safe to Pair With Most HIV Meds

Gilead’s investigational hepatitis C treatment Sovaldi/velpatasvir can be combined safely with most boosted HIV treatments.

Hep C Screening Among Baby Boomers Is Inadequate, And Those With Medicaid Are Less Likely To Be Treated

Despite guidelines calling for universal testing of hepatitis C virus (HCV) among baby boomers, testing rates remain low.

Hepatitis C Cure is Linked to Lowered Risk of Death, Kidney Disease and Diabetes in Those With HIV

Curing hepatitis C virus (HCV) is associated with a reduced risk of death, kidney disease and diabetes.

The Big Hepatitis C News Out of the CROI Medical Conference in Boston

A review of important hep C-related medical research presented at a recent medical conference focusing on retroviruses.

Poorly Controlled HIV is Independently Linked to Liver Fibrosis Progression in Those With and Without Hepatitis C

A high HIV viral load and a low CD4 count are each independently linked to liver fibrosis progression among those with and without hep C.

MUST read

Hepatitis C: The Basics
Hepatitis B: The Basics
Hepatitis A: The Basics

Acute Hep C Infection is Linked With Sexual Behavior Among HIV-Positive Gay Men

HIV-positive gay and bi men are more likely to be acutely (very recently) infected with hepatitis C if they have casual sex partners.

Liver Fibrosis Severity is Tied to Cognitive Dysfunction in Women Independent of HIV or Hepatitis C Status

The severity of liver fibrosis is associated with cognitive dysfunction independent of hepatitis C or HIV status.

A Massive Scale-Up of Hep C Treatment Among Injection Drug Users is Needed to Reap a Prevention Benefit

A massive scale-up of hep C treatment in injection drug users would be required to lower the rate of new infections among the population.

Does Hep C Exposure Raise the Risk of Kidney Disease and Osteoporosis in People With HIV?

A recent study says HIV-positive people who contract hepatitis C have an increased risk of kidney disease and osteoporosis, even if cured.

Hep C Relapses Are Uncommon Among Those Proclaimed Cured, But Reinfection is a Concern

People with hepatitis C very rarely have a viral relapse after acheiving a sustained virologic response 12 weeks after finishing treatment.

Hot topics

Forums: Support and discussion
Blogs: The community speaks

Coffee May Reduce the Risk of Death Among Those Coinfected with HIV and Hepatitis C

Drinking at least three cups of coffee a day is linked with a lowered risk of death among people coinfected with HIV and hepatitis C.

Near Perfect Hepatitis C Cure Rate For Ravidasvir and Sovaldi Among Those With Genotype 4

Sovaldi (sofosbuvir) and ravidasvir, with or without ribavirin, cured almost all people with genotype 4 of hepatitis C in a large trial.

Crystal Meth Use is Strongly Linked to Sexual Acquisition of Hepatitis C in HIV-Positive Gay Men

Among HIV-positive men who have sex with men, crystal meth use is associated with a much higher risk of contracting hepatitis C sexually.

In Real-World Practice, Sovaldi–Based Hep C Regimens Have High Cure Rates Among Those With HIV

Sovaldi (sofosbuvir)–based hepatitis C regimens boast high cure rates in real-world practice among those coinfected with HIV.

Urban Injection Drug Users Succeed on Hep C Treatment With Hands-On Care Protocol

A intensive care coordination program showed a high level of success in getting a group of urban people with hep C cured of the virus.
Advertisement
Treatment News
Newsfeed
Features
Ask Hep